Thomas Navarro FDA Patient Rights Act
This bill died when its Congress ended.
Bills don't carry over between Congresses. Without re-introduction in a new session, it cannot advance.
Thomas Navarro FDA Patient Rights Act - Amends the Public Health Service Act to prohibit the Secretary of Health and Human Services from placing a clinical hold on an investigation of a drug on the basis that the Secretary has determined that: (1) there is another drug (including another investigational drug) that is or may be a safe and effective therapy for the disease or condition involved; or (2) there is a comparable or satisfactory alternative therapy available for a patient who is receiving or will receive the drug as a clinical subject in the investigation, subject to exception.
Filed in the House
This house bill has been filed and is working its way through Congress. It will need to pass both the House and the Senate, then be signed by the President to become law.
Who introduced this
Ask AI About This Bill
Get plain-language answers with direct quotes from the bill text.
Your Representatives
Enter your address to see how your representatives voted on this bill.
Your address is only used to find your district and is never saved. See how it works
Votes
Public Opinion
No votes yet — be the first to weigh in.
to cast your vote
Your voice matters — let representatives know where you stand.
Comments
No comments yet. to be the first to weigh in.